Impact of chronic headache on workdays, unemployment and disutility in the general population.


Journal

Journal of epidemiology and community health
ISSN: 1470-2738
Titre abrégé: J Epidemiol Community Health
Pays: England
ID NLM: 7909766

Informations de publication

Date de publication:
04 2019
Historique:
received: 01 06 2018
revised: 04 12 2018
accepted: 12 12 2018
pubmed: 27 1 2019
medline: 22 5 2020
entrez: 27 1 2019
Statut: ppublish

Résumé

Data on the socioeconomic burden of chronic headache (≥15 days/last month or 30 000 persons aged 30-44 from the general population were screened for chronic headache by a screening questionnaire. The responder rate was 71%. The International Classification of Headache Disorders was used. We analysed the association of chronic headache with lost workdays, days with ≥50% reduced productivity, sick leave, unemployment and disutility, as assessed with the Short-Form Six-Dimension (SF-6D) in separate regression analyses. Eighty-three per cent (427/516, 79% women) of the eligible participants completed the data on workdays and utility. They reported a mean of 9.7 (SD 24.8) workdays lost over the last 3 months, because of headache. The mean disutility score (1-SF-6D score) was 0.41. Thirty-three per cent were on long-term (>1 year) sick leave. The OR for being on sick leave was 1.9 (95% CI 1.1 to 3.2, p=0.017) for those with secondary compared with primary chronic headache. Similarly, the OR for increased number of workdays lost to headache was 3.5 (95% CI 1.8 to 6.5, p<0.001) and for unemployment 1.7 (95% CI 1.0 to 2.9, p=0.07), for those with secondary compared with primary chronic headache. Secondary chronic headache, high headache frequency and high psychological distress were significantly associated with higher disutility score. The burden of chronic headache in the general population is substantial with high rates of lost workdays and disutility.

Sections du résumé

BACKGROUND
Data on the socioeconomic burden of chronic headache (≥15 days/last month or
METHODS
30 000 persons aged 30-44 from the general population were screened for chronic headache by a screening questionnaire. The responder rate was 71%. The International Classification of Headache Disorders was used. We analysed the association of chronic headache with lost workdays, days with ≥50% reduced productivity, sick leave, unemployment and disutility, as assessed with the Short-Form Six-Dimension (SF-6D) in separate regression analyses.
RESULTS
Eighty-three per cent (427/516, 79% women) of the eligible participants completed the data on workdays and utility. They reported a mean of 9.7 (SD 24.8) workdays lost over the last 3 months, because of headache. The mean disutility score (1-SF-6D score) was 0.41. Thirty-three per cent were on long-term (>1 year) sick leave. The OR for being on sick leave was 1.9 (95% CI 1.1 to 3.2, p=0.017) for those with secondary compared with primary chronic headache. Similarly, the OR for increased number of workdays lost to headache was 3.5 (95% CI 1.8 to 6.5, p<0.001) and for unemployment 1.7 (95% CI 1.0 to 2.9, p=0.07), for those with secondary compared with primary chronic headache. Secondary chronic headache, high headache frequency and high psychological distress were significantly associated with higher disutility score.
CONCLUSIONS
The burden of chronic headache in the general population is substantial with high rates of lost workdays and disutility.

Identifiants

pubmed: 30683804
pii: jech-2018-211127
doi: 10.1136/jech-2018-211127
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

360-367

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Espen Saxhaug Kristoffersen (ES)

Head and Neck Research Group, Research Centre, Akershus Universitetssykehus HF, Lorenskog, Norway.
Department of General Practice, HELSAM, University of Oslo, Oslo, Norway.
Department of Neurology, Akershus University Hospital, Lorenskog, Norway.

Knut Stavem (K)

Institute of Clinical Medicine, Campus Akershus University Hospital, University of Oslo, Oslo, Norway.
Department of Pulmonary Medicine, Medical Division, Akershus University Hospital, Lorenskog, Norway.
HØKH, Research Centre, Akershus University Hospital, Lørenskog, Norway.

Christofer Lundqvist (C)

Head and Neck Research Group, Research Centre, Akershus Universitetssykehus HF, Lorenskog, Norway.
Institute of Clinical Medicine, Campus Akershus University Hospital, University of Oslo, Oslo, Norway.
HØKH, Research Centre, Akershus University Hospital, Lørenskog, Norway.
Department of Neurology, Akershus University Hospital, Lorenskog, Norway.

Michael Bjørn Russell (MB)

Head and Neck Research Group, Research Centre, Akershus Universitetssykehus HF, Lorenskog, Norway.
Institute of Clinical Medicine, Campus Akershus University Hospital, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH